Infection with the novel coronavirus SARS-CoV-2 leading to coronavirus disease-2019 (COVID-19) has a broad spectrum of clinical presentations and disease severity. A number of host and viral factors contribute to this heterogeneity in presentation and severity, including the host immune response [1]. Given that immune-mediated inflammatory diseases (IMIDs) including Inflammatory Bowel Disease (IBD), are characterised by immune dysregulation and use of biologic or immunosuppressive therapies, COVID-19 presents a particular challenge.
Acute Severe Ulcerative Colitis (ASUC) is a medical emergency which affects about 25% of UC patients at least once in their lifetime [1]. Corticosteroids are the mainstay of treatment for ASUC; however, 30%–40% of patients do not respond and eventually need medical rescue therapy or surgery [2].Medical rescue therapy (in the form of ciclosporin or infliximab) can be costly and its use can be limited by side effects. Therefore, there is a need for safe and low-cost therapy which can augment the effect of corticosteroids to induce and maintain remission.
Due to the pandemic, we unfortunately were unable to meet and interact physically in the usual way during our most recent Y-ECCO Basic Science Workshop. However, this is exactly what Y-ECCO is about: connecting people, colleagues and friends, clinicians and scientists in order to bring basic science from the bench to the bed, and back. Every year, the Y-ECCO Committee invites outstanding senior experts to give a state-of-the-art overview on hot topics in the IBD field. Furthermore, these top-notch speakers not only moderate the discussions that follow abstract presentations but also inspire and stimulate young researchers and clinician-scientists at the start of their careers. Although this year’s workshop was virtual, we succeeded in continuing our interactive format, with excellent talks and many questions via the virtual platform chat.
I personally found it very well organised and without major technical problems. And the programme was once again fantastic! As always, it was great to witness the many dedicated and brilliant researchers/physicians who work towards improving the care of IBD patients. But let’s hope that this is the last time that we cannot meet in person.
The past 2 years, 2020 and 2021, have been challenging for everybody, but with the help of the ever-enthusiastic ECCO Organisation and their co-workers, the H-ECCO Committee was able to organise a well-attended masterclass at the recent virtual congress in July.
We divided the masterclass into four sessions: Basics of IBD, Scoring Schemes and Standards, Neoplasia and New Concepts in IBD.
As a part of the 16th Congress of ECCO, the 6th D-ECCO (Dietitians of ECCO) Workshop was conducted virtually, with 84 participants. The workshop was divided into three sessions: (1) Science, diet and IBD; (2) Practical clinical nutrition in IBD; and (3) Panel discussion and interactive session.
Who would have thought that ECCO could so smoothly organise such a big conference online? This is the first year that the N-ECCO School has been held as a virtual conference. In reality, this meant less networking among participants but at the same time it provided an incredible opportunity for many more nurses and dietitians from different countries to attend this wonderful course, which provides so much information. In addition, access is being provided to all the presentations at a later date.
The 15th N-ECCO Network Meeting made history this year in being the first network meeting to be delivered virtually. Both the programme and its delivery were a great success. A total of 159 nurses joined the sessions and the virtual format made it easier for participants to ask questions.
The ECCO Postgraduate Course (PGC) in IBD is underway! While the 1st ECCO PGC was by necessity virtual, there is no doubt that we made history. Two hundred and forty participants registered from within and beyond Europe in order to gain intensive education in Inflammatory Bowel Diseases (IBD).
The 19th IBD Intensive Course for Trainees was held virtually on July 2, one week before the ECCO Congress, as part of the educational programme.
This oldest and most established course took place once again this year, although in a virtual design, and was attended by a total of 100 physicians from 33 countries from Europe and elsewhere. The course offered a comprehensive update on IBD and provided pivotal insights into the medical management for IBD patients in an interactive manner.
Bram Verstockt
Johan Burisch
Gert De Hertogh
Lihi Godny
Ana Ibarra
Henit Yanai
